What is the management of Antepartum Hemorrhage (APH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Antepartum Hemorrhage (APH)

Antepartum hemorrhage requires immediate resuscitation, accurate diagnosis, and appropriate management based on the underlying cause, with placenta previa and placental abruption being the most common etiologies.

Definition and Epidemiology

  • APH is defined as any vaginal bleeding from the genital tract after 20 weeks of gestation until delivery 1
  • Complicates 2-5% of pregnancies globally 2
  • Major causes include:
    • Placental abruption (44%)
    • Placenta previa (32%)
    • Undetermined causes (24%) 2

Initial Assessment and Resuscitation

  1. Maternal Stabilization

    • Assess vital signs for signs of hypovolemia (tachycardia, hypotension)
    • Establish two large-bore IV access
    • Send blood samples for complete blood count, coagulation profile, and cross-matching
    • Administer oxygen if signs of maternal compromise
    • Position patient in left lateral position to prevent aortocaval compression
  2. Fetal Assessment

    • Continuous electronic fetal monitoring
    • Ultrasound assessment for fetal viability, presentation, and estimated fetal weight

Diagnostic Approach

  1. History

    • Timing, amount, and character of bleeding
    • Associated pain (suggests abruption)
    • Previous cesarean deliveries (increased risk of placenta previa/accreta)
  2. Examination

    • Avoid digital vaginal examination until placenta previa is excluded
    • Assess uterine tone and tenderness
    • Monitor vital signs and bleeding amount
  3. Investigations

    • Ultrasound (transabdominal and/or transvaginal) to determine placental location
    • Laboratory tests: CBC, coagulation profile, fibrinogen level
    • Maintain fibrinogen levels >200 mg/dL 3
    • Maintain platelet count >50,000/mm³ 3

Management Based on Etiology

1. Placenta Previa

  • Conservative Management (if not actively bleeding and preterm):

    • Hospitalization or modified bed rest
    • Corticosteroids if <34 weeks for fetal lung maturity
    • Serial ultrasound monitoring
    • Avoid sexual intercourse and strenuous activity
  • Delivery Indications:

    • Active bleeding not responding to conservative measures
    • Term gestation (37-38 weeks)
    • Evidence of fetal compromise
    • Mode of delivery: Cesarean section 2

2. Placental Abruption

  • Management:

    • Continuous maternal and fetal monitoring
    • Blood product replacement as needed
    • Correction of coagulopathy if present
  • Delivery Indications:

    • Severe abruption
    • Fetal distress
    • Term gestation
    • Mode of delivery: Vaginal delivery if stable and progressing; otherwise, cesarean section

3. Undetermined Cause

  • Exclude other causes (cervical lesions, trauma)
  • Management based on severity of bleeding, gestational age, and fetal status

Management of Complications

1. Maternal Complications

  • Postpartum Hemorrhage (most common complication, 40% of APH cases) 2

    • Active management of third stage of labor
    • Uterotonic agents (oxytocin, ergot derivatives, prostaglandins) 3
    • Uterine massage
    • Bimanual compression if needed
  • Disseminated Intravascular Coagulation (DIC)

    • Early hemostatic resuscitation with 1:1:1 ratio of red blood cells, fresh frozen plasma, and platelets 3
    • Do not delay transfusion waiting for laboratory results 3
  • Severe Hemorrhage

    • Consider uterine tamponade with balloon or packing
    • Arterial embolization if available
    • Surgical interventions: arterial ligation, pelvic packing
    • Hysterectomy as last resort 3

2. Fetal Complications

  • Preterm birth
  • Low birth weight
  • Fetal distress
  • Intrauterine fetal death (occurs in 42.8% of APH cases) 4

Special Considerations for Delivery

  1. Anesthesia

    • Regional anesthesia (epidural/spinal) preferred if hemodynamically stable
    • General anesthesia may be required for massive hemorrhage or maternal instability
  2. Post-delivery Care

    • Maintain body temperature >36°C to support coagulation 3
    • Correct acidosis
    • Redose antibiotics if blood loss >1500 ml 3
    • Intensive monitoring for at least 24 hours

Prevention Strategies

  • Regular antenatal care
  • Early identification and management of risk factors
  • Every obstetric unit should have a clear protocol for management of massive hemorrhage 1
  • Regular drills and training for emergency management

Prognosis

  • Maternal mortality: 2% (primarily from abruption) 4
  • Perinatal mortality: 18% overall 2
  • Increased risk of recurrence in subsequent pregnancies

APH remains a significant cause of maternal and perinatal morbidity and mortality, requiring prompt recognition and management to improve outcomes.

References

Research

Ante-partum haemorrhage: an update.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2008

Research

Fetomaternal Outcome in Antepartum Hemorrhage After 34 Weeks of Gestation.

Journal of Nepal Health Research Council, 2024

Guideline

Postpartum Hemorrhage Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antepartum Hemorrhage: A Retrospective Analysis from a Northern Nigerian Teaching Hospital.

International journal of applied & basic medical research, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.